← Back to all trials
Completed
NCT05720728
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
Conditions: Candida Infection
Sex: All
Enrollment: 50
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Location: Italy
Summary
Bloodstream infections due to Candida spp remain a serious medical challenge because of their high incidence and poor outcome.
Diagnosis and monitoring of patients are still problematic, hindering efficient clinical management of the disease.
The invastigators propose here to perform a retrospective study in a clinically well-characterized candidemic patient, with the goal of recognizing host immunological factors and virulence-associated fungal molecules relevant in the onset and evolution of infection.
The researchers' ultimate goal is to identify new diagnostic and/or prognostic benchmarks useful in clinical settings.
By combining serologic and immunologic expertise with clinical expertise, the research team has real potential to generate new markers of host pathogenesis and immune response in candidemia and to inform prospective clinical trials to control this terrible disease
Eligibility Criteria
Inclusion Criteria:patients hospitalizedone or more positive blood cultures for Candida spp,positive beta-glucanemiathe presence of at least one clinical symptom of infection will be considered cases of candidemia.Exclusion Criteria:age less than 18 yearsstate of immunosuppressionincompleteness of clinical dataunavailability of serum samples in sufficient quantities for analysis and in good condition.
Source: ClinicalTrials.gov (NCT05720728). StuddyBuddy aggregates publicly available trial information.
